fluorouracil has been researched along with Bannayan-Riley-Ruvalcaba Syndrome in 1 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Čeović, R | 1 |
| Smolković, N | 1 |
| Pašić, A | 1 |
| Kostović, K | 1 |
| Hrsan, D | 1 |
1 other study available for fluorouracil and Bannayan-Riley-Ruvalcaba Syndrome
| Article | Year |
|---|---|
Multiple basal cell carcinomas of lower legs with stasis dermatitis: a therapeutic challenge.
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Hamartoma S | 2012 |